Martin Shkreli

Martin Shkreli

Australia AustraliaentrepreneurMaleb. 19833.0Global Dominance: 0.00%

Martin Shkreli, often referred to as 'Pharma Bro,' is a former pharmaceutical executive who gained notoriety for raising the price of the life-saving drug Daraprim. He was convicted of securities fraud in 2017 and is currently serving time in prison, becoming a symbol of corporate greed and unethical practices in the pharmaceutical industry.

Power1,180
Reach21,813

Country presence

Recent news mentions

Martin Shkreli wants to make one thing clear to anyone who’s willing to listen: He’s back and he still doesn’t care how many people he ticks off along the way.

‘The most hated man in America’ is back and ready to fight everyone
The Sydney Morning Herald·AustraliaAustralia· 2026-07-31
3.0

FCI Fort Dix has been home to a number of high-profile inmates over the years, including 'Pharma Bro' Martin Shkreli.

Sean 'Diddy' Combs' lawyers want him sent to a New Jersey federal prison that offers drug treatment | Entertainment
The Gleaner – major Jamaican newspaper, est. 1834·JamaicaJamaica· 2025-10-07
5.0

Martin Shkreli raised his paddle at a live auction to buy a record for $2 million.

DIANE PHILLIPS: Maybe you should have kept those old records and magazines...
The Tribune – major Bahamian daily, est. 1903·BahamasBahamas· 2025-04-29
3.0

Martin Shkreli bought the single copy of the album Once Upon a Time in Shaolin for $2m.

No longer ‘forever’? Wu-Tang Clan hint at breakup with final world tour | Wu-Tang Clan
The Guardian·United KingdomUnited Kingdom· 2025-02-24
3.0

Martin Shkreli became infamous for drastically raising the price of a life-saving drug.

Index - FOMO - Van visszaút a százmilliós csalással vádolt Hawk Tuah-lány számára?
Index.hu·HungaryHungary· 2025-02-10
2.0

Martin Shkreli is mentioned as a pharmaceuticals fraudster in the context of the Forbes '30 Under 30 curse'.

Fraud trial of Forbes ‘30 Under 30’ honoree set to lift lid on startup culture | Entrepreneurs
The Guardian·United KingdomUnited Kingdom· 2025-02-10
1.0